Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Antoni, Guillemette ^a,b,c   Oudot Mellakh, Tiphaine ^b   Dimitromanolakis, Apostolos ^c   Germain, Marine ^a,b   Cohen, William ^a,d   Wells, Philip ^e   Lathrop, Mark ^f   Gagnon, France ^c   Morange, Pierre Emmanuel ^a,d   Tregouet, David Alexandre ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITY OF TORONTO   (Canada)

^d AIX MARSEILLE UNIVERSITY   (France)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MEMBRANE PROTEIN; VON WILLEBRAND FACTOR; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CLEC4M PROTEIN, HUMAN; DEGENERIN EPITHELIAL SODIUM CHANNELS; EPITHELIAL SODIUM CHANNEL; LECTIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; SCARA5 PROTEIN, MOUSE; SCAVENGER RECEPTOR A; STAB2 PROTEIN, HUMAN; STX2 PROTEIN, HUMAN; STXBP5 PROTEIN, HUMAN; SYNAPTOBREVIN; SYNTAXIN 1;

ARTICLE; BLOOD LEVEL; CLEC4M GENE; GENE; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; HEREDITY; HUMAN; META ANALYSIS; SCARA5 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STAB2 GENE; STX2 GENE; STXBP5 GENE; TC2N GENE; VEIN THROMBOSIS; ADULT; FEMALE; GENETICS; GENOTYPE; MALE; MIDDLE AGED;

ADULT; CELL ADHESION MOLECULES; CELL ADHESION MOLECULES, NEURONAL; EPITHELIAL SODIUM CHANNEL; FACTOR VIII; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; R-SNARE PROTEINS; RECEPTORS, CELL SURFACE; SCAVENGER RECEPTORS, CLASS A; SYNTAXIN 1; VENOUS THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 79960890548     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-102     Document Type: Article

References (34)

1. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995, 345:152-155. 10.1016/S0140-6736(95)90166-3, 7823669.
2. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000, 83:5-9.
3. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002, 113:636-642. 10.1016/S0002-9343(02)01345-1, 12505113.
4. van Schie MC, de Maat MP, Isaacs A, van Duin CM, Deckers JW, Dippel DW, et al. Variation in the von Willebrand Factor gene is associated with VWF levels and with the risk of cardiovascular disease. Blood 2011, 117:1393-1399. 10.1182/blood-2010-03-273961, 20940418.
5. Martinelli N, Girelli D, Lunghi B, Pinotti M, Marchetti G, Malerba G, et al. Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood 2010, 116:5688-5697. 10.1182/blood-2010-03-277079, 20810930.
6. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002, 23:1764-1770. 10.1053/euhj.2001.3237, 12419296.
7. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999, 100:736-742.
8. Cambronero F, Vilchez JA, Garcia-Honrubia A, Ruiz-Espejo F, Moreno V, Hernandez-Romero D, et al. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res 2010, 126:e46-50. 10.1016/j.thromres.2010.01.010, 20156645.
9. Antoni G, Morange PE, Luo Y, Saut N, Burgos G, Heath S, et al. A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost 2010, 8:2671-2679. 10.1111/j.1538-7836.2010.04092.x, 20946148.
10. Vormittag R, Bencur P, Ay C, Tengler T, Vukovich T, Quehenberger P, et al. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism. J Thromb Haemost 2007, 5:497-4502. 10.1111/j.1538-7836.2007.02337.x, 17155964.
11. Carpeggiani C, Coceani M, Landi P, Michelassi C, L'Abbate A. ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010, 211:461-466. 10.1016/j.atherosclerosis.2010.03.012, 20371059.
12. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, Gieger C, et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010, 3:331-339. 10.1161/CIRCGENETICS.109.907873, 20529992.
13. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010, 19:1863-1872. 10.1093/hmg/ddq061, 2850624, 20167578.
14. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000, 101:1546-1551.
15. Morange PE, Tregouet DA, Frere C, Saut N, Pellegrina L, Alessi MC, et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol 2005, 128:91-99. 10.1111/j.1365-2141.2004.05275.x, 15606554.
16. Smith NL, Chen M-H, Dehghan A, Strachan DP, Basu S, Soranzo N, et al. Novel associations of multiple genetic loci with plasma levels of Factor VII, Factor VIII and von Willebrand Factor. The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 2010, 121:1392-1392.
17. Abecasis GR, Cookson WO, Cardon LR. The power to detect linkage disequilibrium with quantitative traits in selected samples. Am J Hum Genet 2001, 68:1463-1474. 10.1086/320590, 1226133, 11349228.
18. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713. 10.1038/nature09270, 3039276, 20686565.
19. Tregouet DA, Heath S, Saut N, Biron-Andreani C, Scheved JF, Pernod G, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009, 113:5298-5303. 10.1182/blood-2008-11-190389, 19278955.
20. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004, 164:2335-2342. 10.1001/archinte.164.21.2335, 15557412.
21. Sun L, Wilder K, McPeek MS. Enhanced pedigree error detection. Hum Hered 2002, 54:99-110. 10.1159/000067666, 12566741.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. 10.1038/ng1847, 16862161.
24. Peng B, Yu RK, Dehoff KL, Amos CI. Normalizing a large number of quantitative traits using empirical normal quantile transformation. BMC Proc 2007, 1(Suppl 1):S156. 10.1186/1753-6561-1-s1-s156, 2367615, 18466501.
25. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007, 23:1038-1039. 10.1093/bioinformatics/btm058, 17308338.
26. Magi R, Morris AP. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 2010, 11:288. 10.1186/1471-2105-11-288, 2893603, 20509871.
27. Morange PE, Saut N, Antoni G, Emmerich J, Tregouet DA. Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels. J Thromb Haemost 2011, 9:229-231. 10.1111/j.1538-7836.2010.04082.x, 21029358.
28. Gauderman WJ, Morrison JM. Quanto 1.1: a computer program for power and sample sizee calculations for genetic-epidemiology studies. 2006, http://hydra.usc.edu/gxe
29. Chen YJ, Stevens TH. The VPS8 gene is required for localization and trafficking of the CPY sorting receptor in Saccharomyces cerevisiae. Eur J Cell Biol 1996, 70:289-297.
30. Agaphonov M, Romanova N, Sokolov S, Iline A, Kalebina T, et al. Defect of vacuolar protein sorting stimulates proteolytic processing of human urokinase-type plasminogen activator in the yeast Hansenula polymorpha. FEMS Yeast Res 2005, 5:1029-1035. 10.1016/j.femsyr.2005.07.003, 16181812.
31. Briegel KJ, Baldwin HS, Epstein JA, Joyner AL. Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh. Development 2005, 132:3305-3316. 10.1242/dev.01887, 15958514.
32. Conen KL, Nishimori S, Provot S, Kronenberg HM. The transcriptional cofactor Lbh regulates angiogenesis and endochondral bone formation during fetal bone development. Dev Biol 2009, 333:348-358. 10.1016/j.ydbio.2009.07.003, 2760734, 19607824.
33. Mori M, Murata Y, Kotani T, Kusakari S, Ohnishi H, Saito Y. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. J Cell Physiol 2010, 224:195-204.
34. Vila-Carriles WH, Kovacs GG, Jovov B, Zhou ZH, Pahwa AK, Colby G, et al. Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. J Biol Chem 2006, 281:19220-19232. 10.1074/jbc.M603100200, 16704974.